Evaluating of suppressive effect of remifentanil on responses to the endotracheal tube during emergence from general anesthesia.

Not Applicable

• Conditions: Condition 1: heart rate. Condition 2: systolic blood pressure. Condition 3: cough. Condition 4: nausea-vomiting.; Symptoms and signs involving the circulatory and respiratory systems; Abnormal blood-pressure reading, without diagnosis; Cough; Nausea and vomiting

• Registration Number: IRCT201103186089N1
• Lead Sponsor: Ahvaz Jundishapur University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

patients aged 18-40 years ; ASA classI; undergoing nasal surgery.
Exclusion criteria: patients under 18 years; above 40 years; history of respiratory infection ; history of irritable airway; difficult intubation; G-E reflux; post-op PONV;motion sickness.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Heart rate,systolic blood pressure,cough,nausea-vomiting. Timepoint: from end of surgery to 4 min after extubation. Method of measurement: noninvasive blood pressure monitoring, pulse oxymeter, scoring system of coughing & nausea-vomiting.

Secondary Outcome Measures

Name	Time	Method
The time of extubation ,arrive to recovery and discharge from recovery. Timepoint: from end of surgery to discharge from recovery. Method of measurement: cornometer.